Adverse events34

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 34

Type	Event	Organ system	Group	Affected	At risk
other	Total GI Disorders	Gastrointestinal disorders	Omega-3 Pentaenoic Acid (MAT9001)	25	97
other	Total GI Disorders	Gastrointestinal disorders	Icosapent Ethyl (Vascepa)	11	100
other	Total Infections	Infections and infestations	Omega-3 Pentaenoic Acid (MAT9001)	4	97
other	Total Infections	Infections and infestations	Icosapent Ethyl (Vascepa)	2	100
other	Total Injury	Injury, poisoning and procedural complications	Omega-3 Pentaenoic Acid (MAT9001)	5	97
other	Total Injury	Injury, poisoning and procedural complications	Icosapent Ethyl (Vascepa)	3	100
other	Total Musculoskeletal Disorders	Musculoskeletal and connective tissue disorders	Omega-3 Pentaenoic Acid (MAT9001)	7	97
other	Total Musculoskeletal Disorders	Musculoskeletal and connective tissue disorders	Icosapent Ethyl (Vascepa)	7	100
other	Total Nervous System Disorders	Nervous system disorders	Omega-3 Pentaenoic Acid (MAT9001)	2	97
other	Total Nervous System Disorders	Nervous system disorders	Icosapent Ethyl (Vascepa)	3	100
other	cataract	Eye disorders	Omega-3 Pentaenoic Acid (MAT9001)	0	97
other	cataract	Eye disorders	Icosapent Ethyl (Vascepa)	2	100
other	Abdominal distension	Gastrointestinal disorders	Omega-3 Pentaenoic Acid (MAT9001)	1	97
other	Abdominal distension	Gastrointestinal disorders	Icosapent Ethyl (Vascepa)	2	100
other	Constipation	Gastrointestinal disorders	Omega-3 Pentaenoic Acid (MAT9001)	0	97
other	Constipation	Gastrointestinal disorders	Icosapent Ethyl (Vascepa)	3	100
other	Diarrhea	Gastrointestinal disorders	Omega-3 Pentaenoic Acid (MAT9001)	10	97
other	Diarrhea	Gastrointestinal disorders	Icosapent Ethyl (Vascepa)	4	100
other	Dyspepsia	Gastrointestinal disorders	Omega-3 Pentaenoic Acid (MAT9001)	2	97
other	Dyspepsia	Gastrointestinal disorders	Icosapent Ethyl (Vascepa)	0	100

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04177680/events

API reference For AI assistants

Adverse events34

Sources 3

Read this list from software.